Merck Wins FDA Lipfendra Approval, Exoplanet Atmosphere Boosts Habitability Hope, Lifestyle Changes Prevent Dementia, Macrophage Therapy Slows Aging, and more...

(0:10): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients(2:03): Discovery of Atmosphere on Rocky Exoplanet LHS 1140 b Boosts Hope for Habitability(4:19): WHO: Up to 45% of Dementia Cases Preventable with Lifestyle Changes(6:39): Targeted Macrophage Therapy Slows Aging, Improves Health in Mice: A Step Toward Human Applications(8:51): Aral Sea Drying Releases 748 Million Tons of CO2, Transforming Carbon Sink into Major Emissions SourceTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: WSOC TV